Literature DB >> 24082321

Complementary and alternative medicine usage in cancer patients in southeast of Turkey.

Mehmet Kucukoner1, Zulfikar Bilge, Abdurrahman Isıkdogan, M Ali Kaplan, Ali Inal, Zuhat Urakci.   

Abstract

The aim of this study was to investigate the frequency of complementary and alternative medicine (CAM) methods and clinical characteristics in cancer patients in southeast of Turkey. A total of 324 patients (173 female) were enrolled to this study. Questionnaire was applied to all patients individually for approximately 15 minutes by a doctor. At least one CAM method was used by 62% (n=201) of the patients. 82.5% (n=166) of patients treated with CAM were using at least one herbal species. Likewise, 40.9% (68/166) of these patients were using herbal mixtures and 39.8% (66/166) of them were using single herbal as nettle (Urtica dioica) or its seed, 19.3 % (32/166) of them were using other herbals. CAM methods were preferred more frequently by the patients with metastatic stage (p=0.005), receiving palliative treatment (p<0.001), chemotherapy (p=0.020), in between 40-60 ages patient groups (p=0.002), and when duration of disease was lengthened (p=0.002). CAM use among cancer patients is quite common. Presence of metastatic cancer at diagnosis, receiving chemotherapy and palliative treatment and long disease duration were found as main associated factors for CAM usage.

Entities:  

Keywords:  Complementary and alternative medicine; cancer; herbal therapy

Mesh:

Substances:

Year:  2012        PMID: 24082321      PMCID: PMC3746353          DOI: 10.4314/ajtcam.v10i1.4

Source DB:  PubMed          Journal:  Afr J Tradit Complement Altern Med        ISSN: 2505-0044


  12 in total

1.  The use of complementary therapies in cancer patients: a questionnaire-based descriptive survey from southeastern Turkey.

Authors:  Ozlem Ucan; Seda Pehlivan; Nimet Ovayolu; Alper Sevinc; Celalettin Camci
Journal:  Am J Clin Oncol       Date:  2008-12       Impact factor: 2.339

Review 2.  The prevalence of complementary/alternative medicine in cancer: a systematic review.

Authors:  E Ernst; B R Cassileth
Journal:  Cancer       Date:  1998-08-15       Impact factor: 6.860

3.  Alternative medicine--the risks of untested and unregulated remedies.

Authors:  M Angell; J P Kassirer
Journal:  N Engl J Med       Date:  1998-09-17       Impact factor: 91.245

4.  Survey of the use of complementary and alternative medicine among Turkish cancer patients.

Authors:  S Ceylan; O Hamzaoğlu; S Kömürcü; C Beyan; A Yalçin
Journal:  Complement Ther Med       Date:  2002-06       Impact factor: 2.446

5.  Nationwide survey on complementary and alternative medicine in cancer patients in Japan.

Authors:  Ichinosuke Hyodo; Noriko Amano; Kenji Eguchi; Masaru Narabayashi; Jiro Imanishi; Midori Hirai; Tomohito Nakano; Shigemitsu Takashima
Journal:  J Clin Oncol       Date:  2005-02-22       Impact factor: 44.544

6.  The prevalence and determinants of the use of complementary and alternative medicine in adult Turkish cancer patients.

Authors:  Faruk Tas; Zeki Ustuner; Gulbeyaz Can; Yesim Eralp; Hakan Camlica; Mert Basaran; Hakan Karagol; Burak Sakar; Rian Disci; Erkan Topuz
Journal:  Acta Oncol       Date:  2005       Impact factor: 4.089

7.  Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology.

Authors:  M A Richardson; T Sanders; J L Palmer; A Greisinger; S E Singletary
Journal:  J Clin Oncol       Date:  2000-07       Impact factor: 44.544

8.  Use of complementary and alternative medicine in cancer patients: a European survey.

Authors:  A Molassiotis; P Fernández-Ortega; D Pud; G Ozden; J A Scott; V Panteli; A Margulies; M Browall; M Magri; S Selvekerova; E Madsen; L Milovics; I Bruyns; G Gudmundsdottir; S Hummerston; A M-A Ahmad; N Platin; N Kearney; E Patiraki
Journal:  Ann Oncol       Date:  2005-02-02       Impact factor: 32.976

9.  Pharmacist's role in meeting the psychosocial needs of cancer patients using complementary therapy.

Authors:  Mário L De Lemos
Journal:  Psychooncology       Date:  2005-03       Impact factor: 3.894

10.  Use of complementary and alternative medicine by chinese women with breast cancer.

Authors:  Yong Cui; Xiao-Ou Shu; Yutang Gao; Wanqing Wen; Zhi-Xian Ruan; Fan Jin; Wei Zheng
Journal:  Breast Cancer Res Treat       Date:  2004-06       Impact factor: 4.872

View more
  6 in total

1.  Investigation into Complementary and Integrative Health Approaches for Turkish Patients with Gastrointestinal Cancer.

Authors:  Seda Pehlivan; Ali Süner; Yasemin Yıldırım; Çiçek Fadıloğlu
Journal:  J Relig Health       Date:  2018-08

Review 2.  Prevalence of the Use of Herbal Medicines among Patients with Cancer: A Systematic Review and Meta-Analysis.

Authors:  John Baptist Asiimwe; Prakash B Nagendrappa; Esther C Atukunda; Mauda M Kamatenesi; Grace Nambozi; Casim U Tolo; Patrick E Ogwang; Ahmed M Sarki
Journal:  Evid Based Complement Alternat Med       Date:  2021-05-17       Impact factor: 2.650

Review 3.  Progress in palliative care for cancer in Turkey: a review of the literature.

Authors:  Tezer Kutluk; Fahad Ahmed; Mustafa Cemaloğlu; Burça Aydın; Meltem Şengelen; Meral Kirazli; Sema Yurduşen; Richard Sullivan; Richard Harding
Journal:  Ecancermedicalscience       Date:  2021-11-25

4.  HERBAL PRODUCT USE BY THE CANCER PATIENTS IN BOTH THE PRE AND POST SURGERY PERIODS AND DURING CHEMOTHERAPY.

Authors:  Sema Koçaşlı; Zehra Demircan
Journal:  Afr J Tradit Complement Altern Med       Date:  2017-01-13

5.  Complementary and alternative medicine use among outpatients during the 2015 MERS outbreak in South Korea: a cross-sectional study.

Authors:  Jung Hye Hwang; Hyun Jeong Cho; Hyea Bin Im; Young Sun Jung; Soo Jeung Choi; Dongwoon Han
Journal:  BMC Complement Med Ther       Date:  2020-05-13

6.  In the Turkish News: Coronavirus and "Alternative & complementary" medicine methods.

Authors:  Gulbin Konakci; Berna Nilgun Ozgursoy Uran; Ozum Erkin
Journal:  Complement Ther Med       Date:  2020-08-19       Impact factor: 2.446

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.